Paul Knight
Stock Analyst at Keybanc
(3.36)
# 1,078
Out of 4,412 analysts
122
Total ratings
46.79%
Success rate
2.4%
Average return
Main Sectors:
34 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Overweight | $25 → $28 | $20.34 | +37.66% | 6 | Mar 1, 2024 | |
| RGEN Repligen | Maintains: Overweight | $210 → $220 | $166.58 | +32.07% | 7 | Feb 15, 2024 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $440 → $470 | $360.43 | +30.40% | 10 | Feb 13, 2024 | |
| RVTY Revvity | Maintains: Overweight | $110 → $126 | $101.51 | +24.13% | 2 | Feb 2, 2024 | |
| DHR Danaher | Maintains: Overweight | $260 → $290 | $246.58 | +17.61% | 7 | Feb 1, 2024 | |
| CDMO Avid Bioservices | Maintains: Overweight | $20 → $14 | $7.35 | +90.48% | 5 | Dec 8, 2023 | |
| TECH Bio-Techne | Maintains: Overweight | $115 → $80 | $64.06 | +24.88% | 6 | Nov 1, 2023 | |
| TMO Thermo Fisher | Downgrades: Sector Weight | n/a | $573.60 | - | 6 | Oct 26, 2023 | |
| STVN Stevanato Group | Maintains: Overweight | $35 → $37 | $27.54 | +34.35% | 5 | Aug 30, 2023 | |
| TBIO Telesis Bio | Downgrades: Sector Weight | n/a | $0.32 | - | 1 | Aug 11, 2023 | |
| MRVI Maravai LifeSciences Holdings | Downgrades: Sector Weight | n/a | $7.70 | - | 8 | Aug 8, 2023 | |
| CYRX Cryoport | Downgrades: Sector Weight | n/a | $16.38 | - | 7 | Jul 17, 2023 | |
| TKNO Alpha Teknova | Initiates: Sector Weight | n/a | $1.73 | - | 1 | Jul 12, 2023 | |
| LAB Standard BioTools | Initiates: Overweight | $4 | $2.44 | +63.93% | 1 | Jul 12, 2023 | |
| A Agilent Technologies | Downgrades: Sector Weight | n/a | $137.74 | - | 7 | May 24, 2023 | |
| AZTA Azenta | Downgrades: Sector Weight | n/a | $52.18 | - | 3 | May 10, 2023 | |
| HBIO Harvard Bioscience | Maintains: Overweight | $5 → $7 | $3.62 | +93.37% | 4 | Apr 26, 2023 | |
| CTLT Catalent | Downgrades: Sector Weight | n/a | $55.92 | - | 5 | Dec 19, 2022 | |
| AVTR Avantor | Maintains: Overweight | $51 → $40 | $23.94 | +67.08% | 5 | Sep 15, 2022 | |
| XGN Exagen | Maintains: Overweight | $20 → $17 | $1.41 | +1,103.88% | 5 | May 13, 2022 | |
| BLFS BioLife Solutions | Maintains: Overweight | $60 → $30 | $17.53 | +71.14% | 3 | May 10, 2022 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $390 → $300 | $229.03 | +30.99% | 1 | May 5, 2022 | |
| IQV IQVIA Holdings | Maintains: Overweight | $290 → $250 | $234.88 | +6.44% | 1 | Apr 28, 2022 | |
| OCX OncoCyte | Downgrades: Sector Weight | n/a | $2.48 | - | 2 | Mar 14, 2022 | |
| TFX Teleflex | Maintains: Overweight | n/a | $206.71 | - | 1 | Jan 8, 2021 | |
| ICUI ICU Medical | Maintains: Overweight | n/a | $94.84 | - | 1 | Jan 8, 2021 | |
| COO The Cooper Companies | Maintains: Overweight | $92 → $99 | $88.84 | +11.44% | 1 | Jan 8, 2021 | |
| AVNS Avanos Medical | Maintains: Overweight | n/a | $18.10 | - | 1 | Jan 8, 2021 | |
| WAT Waters | Initiates: Sector Weight | n/a | $311.30 | - | 3 | Nov 10, 2020 | |
| VCYT Veracyte | Initiates: Sector Weight | n/a | $19.31 | - | 3 | Nov 10, 2020 | |
| SCND Scientific Industries | Initiates: Sector Weight | n/a | $1.75 | - | 1 | Nov 10, 2020 | |
| MLAB Mesa Laboratories | Initiates: Sector Weight | n/a | $103.19 | - | 1 | Nov 10, 2020 | |
| IDXG Interpace Biosciences | Initiates: Buy | n/a | $1.50 | - | 1 | Apr 15, 2020 | |
| ILMN Illumina | Upgrades: Neutral | n/a | $122.28 | - | 1 | Oct 23, 2017 |
Castle Biosciences
Mar 1, 2024
Maintains: Overweight
Price Target: $25 → $28
Current: $20.34
Upside: +37.66%
Repligen
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $166.58
Upside: +32.07%
West Pharmaceutical Services
Feb 13, 2024
Maintains: Overweight
Price Target: $440 → $470
Current: $360.43
Upside: +30.40%
Revvity
Feb 2, 2024
Maintains: Overweight
Price Target: $110 → $126
Current: $101.51
Upside: +24.13%
Danaher
Feb 1, 2024
Maintains: Overweight
Price Target: $260 → $290
Current: $246.58
Upside: +17.61%
Avid Bioservices
Dec 8, 2023
Maintains: Overweight
Price Target: $20 → $14
Current: $7.35
Upside: +90.48%
Bio-Techne
Nov 1, 2023
Maintains: Overweight
Price Target: $115 → $80
Current: $64.06
Upside: +24.88%
Thermo Fisher
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $573.60
Upside: -
Stevanato Group
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $27.54
Upside: +34.35%
Telesis Bio
Aug 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $0.32
Upside: -
Maravai LifeSciences Holdings
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $7.70
Upside: -
Cryoport
Jul 17, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $16.38
Upside: -
Alpha Teknova
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $1.73
Upside: -
Standard BioTools
Jul 12, 2023
Initiates: Overweight
Price Target: $4
Current: $2.44
Upside: +63.93%
Agilent Technologies
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $137.74
Upside: -
Azenta
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $52.18
Upside: -
Harvard Bioscience
Apr 26, 2023
Maintains: Overweight
Price Target: $5 → $7
Current: $3.62
Upside: +93.37%
Catalent
Dec 19, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $55.92
Upside: -
Avantor
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $23.94
Upside: +67.08%
Exagen
May 13, 2022
Maintains: Overweight
Price Target: $20 → $17
Current: $1.41
Upside: +1,103.88%
BioLife Solutions
May 10, 2022
Maintains: Overweight
Price Target: $60 → $30
Current: $17.53
Upside: +71.14%
Charles River Laboratories International
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $229.03
Upside: +30.99%
IQVIA Holdings
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $234.88
Upside: +6.44%
OncoCyte
Mar 14, 2022
Downgrades: Sector Weight
Price Target: n/a
Current: $2.48
Upside: -
Teleflex
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $206.71
Upside: -
ICU Medical
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $94.84
Upside: -
The Cooper Companies
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $88.84
Upside: +11.44%
Avanos Medical
Jan 8, 2021
Maintains: Overweight
Price Target: n/a
Current: $18.10
Upside: -
Waters
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $311.30
Upside: -
Veracyte
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $19.31
Upside: -
Scientific Industries
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $1.75
Upside: -
Mesa Laboratories
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $103.19
Upside: -
Interpace Biosciences
Apr 15, 2020
Initiates: Buy
Price Target: n/a
Current: $1.50
Upside: -
Illumina
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $122.28
Upside: -